In the face of tremendous uncertainty during the current pandemic, there is a need for clear and consistent recommendations and an understanding of the evidence in general, and for families of children with allergic conditions. A common concern of parents of children with asthma is the risk that in-person learning poses during the pandemic . This Rostrum examines the actual risk of in-person learning among children with asthma during COVID-19, the discrepancy between perceived and actual risk, the contributing factors to this discrepancy, and possible solutions to narrow this divide . Overall, the evidence does not support that children with asthma are at an increased risk of COVID-19 morbidity or mortality compared to children without asthma . Asthma medications do not appear to contribute to incidence or severity of COVID-19 disease . However, there is a high perceived risk of in-person learning that is partially related to how it is portrayed in the media . There is little guidance regarding transitioning asthmatic children back to school and how to properly counsel on mediation of risk . There are differences regionally and locally around school reopening, exemptions, and their implementation . To narrow the divide between perceived and actual risk, clear consistent and ongoing communication will be necessary.